QA: NVN Liquidation Inc in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001467154_2022_NVN_Liquidation_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Large missing amount for aggregate "Revenues" added to remainder. industry.us_generic {'missing_ratio': inf, 'aggregate_val': 2958000, 'exp_sum': 0, 'exp_to_value': {'remainder_Revenues': 0}}

Graph

Absolute values for 0001467154, NVN Liquidation Inc

  xvar xval
0 AssetsCurrent 54,130,000
1 IntangibleAssetsNetIncludingGoodwill 75,000
2 PropertyPlantAndEquipmentNet 12,201,000
3 remainder_Assets 2,554,000
4 LiabilitiesCurrent 11,150,000
5 LiabilitiesNoncurrent 14,349,000
6 remainder_Liabilities 25,142,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 12,314,448
9 ResearchAndDevelopmentExpense 20,250,443
10 remainder_Expenses 3,734,739
11 remainder_Revenues 3,570,776
12 remainder_NetIncome 388,727
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 68,960,000
1 Liabilities 50,641,000
2 Expenses 36,299,630
3 Revenues 3,570,776
4 StockholdersEquity 18,319,000
5 NetIncome -32,340,127
6 ComprehensiveNetIncome -32,340,127
7 BaseVar 79,930,066
8 EconomicCapitalRatiobeforeLimitedLiability 0.127
9 EconomicCapitalRatio 1.54

Edgar->Model Mapping

Feature Distribution

Change over Time